Reteplase biosimilar (Yibai Pharma)
瑞替普酶生物类似药（益佰药业）
Report date: 2022/01/22 15:45:24
Base Information
Drug NameReteplase biosimilar (Yibai Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2003/12/17
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuizhou Yibai Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGuizhou Yibai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A